SG11201606292WA - Methods for evaluating effects of a treatment on biological processes and pathways - Google Patents

Methods for evaluating effects of a treatment on biological processes and pathways

Info

Publication number
SG11201606292WA
SG11201606292WA SG11201606292WA SG11201606292WA SG11201606292WA SG 11201606292W A SG11201606292W A SG 11201606292WA SG 11201606292W A SG11201606292W A SG 11201606292WA SG 11201606292W A SG11201606292W A SG 11201606292WA SG 11201606292W A SG11201606292W A SG 11201606292WA
Authority
SG
Singapore
Prior art keywords
pathways
treatment
methods
biological processes
evaluating effects
Prior art date
Application number
SG11201606292WA
Inventor
Makio Tamura
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SG11201606292WA publication Critical patent/SG11201606292WA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Evolutionary Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201606292WA 2014-03-27 2015-03-19 Methods for evaluating effects of a treatment on biological processes and pathways SG11201606292WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461971062P 2014-03-27 2014-03-27
PCT/US2015/021362 WO2015148236A1 (en) 2014-03-27 2015-03-19 Methods for evaluating effects of a treatment on biological processes and pathways

Publications (1)

Publication Number Publication Date
SG11201606292WA true SG11201606292WA (en) 2016-08-30

Family

ID=54190757

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201606292WA SG11201606292WA (en) 2014-03-27 2015-03-19 Methods for evaluating effects of a treatment on biological processes and pathways

Country Status (5)

Country Link
US (1) US20150278436A1 (en)
EP (1) EP3123379A4 (en)
CN (1) CN106104540A (en)
SG (1) SG11201606292WA (en)
WO (1) WO2015148236A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11721441B2 (en) * 2019-01-15 2023-08-08 Merative Us L.P. Determining drug effectiveness ranking for a patient using machine learning

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002338551A1 (en) * 2001-04-27 2002-11-11 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method and system for identifying targets by nucleocytoplasmic cycling and use thereof
WO2003065282A1 (en) * 2002-02-01 2003-08-07 Rosetta Inpharmatics Llc Computer systems and methods for identifying genes and determining pathways associated with traits
JP5301160B2 (en) * 2004-11-10 2013-09-25 アッタゲネ インコーポレーテッド Reporter sequence populations and methods for their use
CA2758826A1 (en) * 2009-04-18 2010-10-21 Merck Sharp & Dohme Corp. Methods and gene expression signature for assessing ras pathway activity
US9235686B2 (en) * 2012-01-06 2016-01-12 Molecular Health Gmbh Systems and methods for using adverse event data to predict potential side effects

Also Published As

Publication number Publication date
US20150278436A1 (en) 2015-10-01
EP3123379A4 (en) 2017-11-22
WO2015148236A1 (en) 2015-10-01
EP3123379A1 (en) 2017-02-01
CN106104540A (en) 2016-11-09

Similar Documents

Publication Publication Date Title
IL279627A (en) Method for the treatment of depression
HK1248552A1 (en) Method of treatment with tradipitant
GB201401773D0 (en) Incubator apparatus and methods
EP2993160A4 (en) Water treatment device and water treatment method
PT3197839T (en) Method and arrangement for wastewater treatment
GB201410116D0 (en) Method of treatment
IL253028A0 (en) Method of treatment
SG11201703184SA (en) A method of treatment
GB2530285B (en) Hydrophobic treatment for ski and method
GB201416832D0 (en) Methods of treatment
EP2993159A4 (en) Water treatment device and water treatment method
HK1247119A1 (en) A method of treatment and compounds for use therein
SG11201700623YA (en) Biological treatment method and biological treatment device
GB2527046B (en) Device and method for the treatment of crops
SG11201606292WA (en) Methods for evaluating effects of a treatment on biological processes and pathways
GB201401774D0 (en) Incubator apparatus and methods
SG11201800356WA (en) Biological treatment device
IL248847A0 (en) Dosage of dasotraline and method for treatment of adhd
GB201500555D0 (en) Method and device for the treatment of diseases
SG11201701407VA (en) Water treatment device and operating method for same
GB201404265D0 (en) Respiratory analysis and treatment
GB201421980D0 (en) Method of treatment
GB201421982D0 (en) Method of treatment
GB201415331D0 (en) Method of treatment
GB201414780D0 (en) Method Of Treatment